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The  present  study  was  based  on  the  reverse  transcription  polymerase  chain  reaction 
(RT-PCR) of the 16S ribosomal nucleic acid (rRNA) of Mycoplasma for detection of viable 
Mycoplasma gallisepticum. To determine the stability of M. gallisepticum 16S rRNA in vitro, three 
inactivation methods were used and the suspensions were stored at different temperatures. 
The  16S  rRNA  of  M.  gallisepticum  was  detected  up  to  approximately  20–25  h  at  37  °C, 
22–25 h at 16 °C, and 23–27 h at 4 °C. The test, therefore, could detect viable or recently 
dead M. gallisepticum (< 20 h). The RT-PCR method was applied during an in vivo study of 
drug efficacy under experimental conditions, where commercial broiler-breeder eggs were 
inoculated with M. gallisepticum into the yolk. Hatched chicks that had been inoculated in ovo 
were treated with Macrolide 1. The method was then applied in a flock of day 0 chicks with 
naturally acquired vertical transmission of M. gallisepticum, treated with Macrolide 2. Swabs of 
the respiratory tract were obtained for PCR and RT-PCR evaluations to determine the viability 
of M. gallisepticum. This study proved that the combination of both PCR and RT-PCR enables 
detection and differentiation of viable from non-viable M. gallisepticum.
Introduction
Mycoplasmas are the smallest self-replicating prokaryotes and belong to the class Mollicutes, 
Order I, Mycoplasmatales, family Mycoplasmataceae (Razin 1992; Razin, Yogev & Naot 1998). 
Mycoplasmas are devoid of cell walls and bounded by only a plasma membrane (Baseman & 
Tully 1997; Razin 1992); they are therefore resistant to antibiotics that affect cell wall synthesis 
(Kleven 2003). Some mycoplasmas are host specific, whilst others may be able to infect several 
species of animals. Mycoplasmas colonise only mucosal surfaces, where most species remain 
noninvasive, but others such as Mycoplasma gallisepticum are able to penetrate cells (Kleven 
2003). Avian mycoplasmosis has been reported to include chronic respiratory disease, infectious 
sinusitis and infectious synovitis, which result in decreased egg production, reduced growth 
rate and decreased hatchability in poultry (Ley et al. 1997). The species of economic importance 
in poultry that are pathogenic are M. gallisepticum, Mycoplasma synoviae, Mycoplasma meleagridis 
and Mycoplasma iowae. Mycoplasma gallisepticum infection causes chronic respiratory disease in 
chickens. The disease is often complicated by other microorganisms, including respiratory viruses 
and Escherichia coli, which lead to severe air sacculitis and complicated chronic respiratory disease 
(Ley 2003).
The transmission of M. gallisepticum can be both vertical and horizontal. Vertical transmission of 
M. gallisepticum has been known to occur in eggs laid by infected hens. Horizontal transmission 
of  M.  gallisepticum  occurs  through  direct  contact  between  infected  and  susceptible  chickens, 
especially in flocks with high population density (OIE 2004). Indirect transmission can occur 
through  contaminated  aerosol  droplets,  dust,  feathers,  fomites  and  farm  personnel.  Since 
M. gallisepticum can be transmitted vertically, maintaining a M. gallisepticum-free flock is only 
possible by obtaining M. gallisepticum-free chicks or eggs from an M. gallisepticum-free breeder 
flock.  Practising  good  farm  biosecurity  and  establishing  a  flock  health  programme,  such  as 
vaccination and prophylactic antibiotics, may also prevent M. gallisepticum infection (Kleven 1997). 
Although these are practised on many farms, M. gallisepticum still occurs in Malaysia where this 
study was carried out. 
The conventional way of detecting bacterial viability depends on the ability of the bacteria to 
grow actively and form visible colonies on solid media. The number of viable bacteria may 
be severely underestimated by this method, as sub-lethally damaged bacteria (Blackburn & 
McCarthy 2000), fastidious and/or uncultivable bacteria (Ward, Weller & Bateson 1990) and 
viable cells that may lose their ability to form colonies under culture conditions will not be 
detected.  Alternative  methods  for  determining  viability  are  metabolic  activity  and  nucleic 
acid-based analyses (Del Mar Lleo et al. 2000; McCarty & Atlas 1993; Sheridan et al. 1998). A 
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wide  range  of  molecular  targets  have  been  utilised  in 
determining bacterial species present in samples, especially 
polymerase  chain  reaction  (PCR).  However,  these  assays 
do not give any indication of the viability of the bacteria. 
Deoxyribosomal  nucleic  acid  (DNA),  which  has  a  very 
long  half-life  compared  to  ribosomal  nucleic  acid  (RNA) 
(Belasco & Higgins 1988), is a rather stable nucleic acid that 
is detectable in live organisms and may also be detected in 
dead organisms due to its stability in dead cells and even in 
the environment (Del Mar Lleo et al. 2000). 
The precise correlation of cell viability with detection of DNA has 
been shown to be poor, with DNA persisting in actively killed 
bacteria for significant periods of time (Masters, Shallcross 
& Mackey 1994). As RNA is a highly labile molecule with a 
very short half-life it should provide better correlation with 
bacterial viability compared to DNA-based assays. Under a 
bacteria-killing regimen, RNA has been found to positively 
correlate  with  viability  (McKillip,  Jaykus  &  Druke  1998). 
As DNA of dead cells may also be amplified, the detection 
of M. gallisepticum by PCR is not a direct indication of its 
viability or infectivity (Josephson, Gerber & Pepper 1993); it 
shows that the organism was present, due to either a current 
or  a  former  infection  that  had  occurred  at  an  uncertain 
time. Because only viable mycoplasmas are of concern as a 
potential source of infection, their detection is of the utmost 
importance. Since ribosomal RNA (rRNA) is less stable than 
DNA (McKillip et al. 1988) and is constitutively expressed, 
it is considered to be a suitable target for development of 
a  reverse  transcription-polymerase  chain  reaction  (RT-
PCR) for detection of viable Mycoplasma cells (Marois et al. 
2002).  This  would  assist  in  determining  mycoplasmacidal 
drug  efficiency  and  also  the  in  vivo  minimum  inhibitory 
concentration.
Mycoplasma  infection  is  thought  to  be  a  lifelong 
infection  by  many,  since  a  previously  infected  flock  that 
has  clinically  recovered  from  the  infection  can  have  a 
recurrence of mycoplasmosis when the flock is challenged 
by  other  complicating  viral  infections  (Kempf  et  al.  1994). 
Currently, there is still lack of information on the viability 
of  M.  gallisepticum  after  antibiotic  treatment,  therefore 
the  true  efficacy  of  drugs  in  eliminating  M.  gallisepticum 
infections  remains  unknown.  Therefore,  the  objectives  of 
this study were: to determine the stability of 16S rRNA after 
M.  gallisepticum  death  in  vitro  under  several  temperature 
conditions; to detect viable and non-viable M. gallisepticum 
using PCR and RT-PCR in combination with an in vivo study 
of drug efficacy; and to apply this method of detection under 
field conditions.
Materials and methods
Mycoplasma strains
Mycoplasma  gallisepticum  strains  used  in  this  study  were 
as  follows:  M.  gallisepticum-S6,  a  reference  strain  obtained 
from the Veterinary Research Institute (VRI), Ipoh, Perak, 
Malaysia; ts-11, a vaccine strain; H21-11T, a local field strain 
isolated from an infected normal chick; and I 29, a local field 
strain isolated from an apparently healthy chicken.
In vitro verification of stability of 16S rRNA after 
mycoplasma death 
The  stability  of  16S  rRNA  was  determined  using  an 
M. gallisepticum reference strain (M. gallisepticum-S6), a vaccine 
strain  (ts-11)  and  a  field  strain  (H21-11T).  Three  methods 
were  used  to  kill  the  mycoplasmas.  Three  suspensions 
of  M.  gallisepticum  were  prepared  as  follows:  1  mL  of 
M. gallisepticum culture of each strain (M. gallisepticum-S6, 
ts-11 and H21-11T) was centrifuged at 12 000 x g for 20 min 
using an Eppendorf centrifuge (Eppendorf 5403, Hamburg, 
Germany) and the supernatant was discarded. In the first 
method, glycerol was added to the pellet and thoroughly 
re-suspended (to prevent cell lysis) and incubated at 95 °C 
for 15 min, as described by Marois et al. (2002). The second 
method  involved  re-suspension  of  the  pellet  in  double-
distilled water (to cause osmotic shock) and incubated for 
1 h at 60 °C, as described by Marois et al. (2002). The third 
method  consisted  of  re-suspending  the  resultant  pellet  in 
phosphate buffer saline and subjecting it to ultrasonic lysis 
for 15 min. 
To  confirm  that  the  mycoplasmas  were  already  dead,  the 
suspensions were inoculated into a ‘pleuropneumonia-like 
organism’  (PPLO)  broth  (mycoplasma  broth,  as  described 
by Tan [2004]) immediately after cell lysis and incubated at 
37 °C. The suspensions of each strain and each method were 
stored at 4 °C, 16 °C and 37 °C. Samples were collected from 
each suspension for DNA and RNA extraction immediately 
before cell lysis and at 0 h, 1 h, 5 h, 15 h, 20 h, 22 h, 23 h, 24 h, 
25 h, 27 h and 48 h after cell lysis. The DNA samples were 
evaluated using PCR. The times (h) when rRNA was last 
detected by PCR for each method and for storage at different 
temperatures  were  recorded  for  the  three  M.  gallisepticum 
strains, and the means were calculated.
Molecular detection of viable and non-viable 
Mycoplasma gallisepticum
The PCR procedures were performed according to the method 
described by Marois et al. (2002) with some modifications. 
Polymerase  chain  reaction  evaluation  was  performed  to 
confirm the presence of M. gallisepticum before an RT-PCR 
was carried out to evaluate the viability of M. gallisepticum. 
Genomic DNA and RNA (total nucleic acid) were extracted 
using a commercially available kit, MasterPure™ Complete 
DNA & RNA Purification Kit from Epicentre® Biotechnologies 
(Wisconsin, USA), according to the method recommended by 
the manufacturer. Polymerase chain reaction amplification 
was performed with 25 µL of reaction mixture containing 
5x  PCR  buffer,  25  mmol  M.  gallisepticum  Cl2,  100  mmol 
deoxynucleoside  triphosphates,  0.1  µm  of  each  primer, 
2.5 units Taq DNA polymerase (Vivantis, Malaysia), PCR-
grade water and 2 µL of extracted total nucleic acid. The PCR 
reaction procedure consisted of an initial denaturation step at 
94 °C for 5 min, followed by 30 cycles of denaturation at 94 °C 
for 30 s, primer annealing at 55 °C for 30 s and extension at 
72 °C for 1 min, and ended with one cycle of final extension 
at 72 °C for 10 min.
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After confirming the presence of M. gallisepticum infection, 
the viability of M. gallisepticum was evaluated by RT-PCR. 
Polymerase chain reaction was also performed on the RNA 
templates to rule out the possibility of any DNA contamination 
that  would  give  a  false  positive  result,  because  the  same 
set of primers was used in both PCR and RT-PCR. DNase 
(Promega,  Madison,  Wisconsin,  USA)  treatment  of  RNA 
samples prior to RT-PCR was performed, as recommended 
by  the  manufacturer.  Repeat  DNA  removal  was  needed 
if the PCR on the DNase treatment of RNA samples was 
found to be positive. The RNA templates were amplified in 
an automatic thermal cycler (MyCycler, BioRad, California, 
USA). The reaction volume was set up in a 25 µL reaction 
master mixture using reagents in an All-in-one RT-PCR Kit 
(Mbiotech, Inc., Seoul, Korea) with 2 µL of template. The RT-
PCR  reaction  procedure  consisted  of  reverse  transcription 
at 48 °C for 40 min, reverse transcriptase inactivation and 
pre-denaturation at 96 °C for 5 min, followed by 35 cycles 
of denaturation at 94 °C for 30 s, primer annealing at 55 °C 
for 30 s and extension at 72 °C for 1 min, and ended with one 
cycle of final extension at 72 °C for 10 min. Polymerase chain 
reaction  amplicons  obtained  from  DNA  and  cDNA  templates 
were separated by using 1.5% agarose gel electrophoresis to 
detect genomic DNA. The sizes of the amplified PCR product 
were compared using a 100 bp DNA ladder.
In vivo experimental study of drug efficacy
Commercial broiler-breeder eggs were obtained from a farm 
in Malaysia with a history of killed vaccine vaccination in 
the  breeder  flock.  The  eggs  from  the  farm  were  divided 
into  two  groups:  an  M.  gallisepticum-inoculated  and  an 
uninoculated group (control group). Intra-yolk inoculation 
with M. gallisepticum strain H 21-11T was performed at day 
6  of  incubation  with  an  M.  gallisepticum  concentration  of 
103 CFU/mL. The eggs were incubated and allowed to hatch.
All  hatched  chicks  were  wing  tagged.  The  chicks  were 
reared in separate cages in an experimental house as follows: 
amongst all the inoculated chicks that hatched, chicks that 
survived subsequently received antimicrobial treatment. The 
chicks were fed with mash concentrate with low bacterial 
counts and no added antibiotics (purchased from VRI, Ipoh, 
Malaysia). The chicks were observed daily for clinical signs 
of mycoplasmosis. 
The first sampling was carried out on day-old chicks. Two 
chicks  were  randomly  chosen  from  each  group.  Choanal 
cleft swabs were obtained from the chosen chicks and two 
swabs  from  the  same  group  were  pooled  as  one  sample. 
Swab samples were immediately stored in PPLO broth that 
had been mixed with an equal volume of sterile glycerol and 
kept at -80 °C. The samples from the first sampling day were 
processed by extraction and amplification of DNA and RNA 
using PCR and RT-PCR, respectively, to verify the presence 
of M. gallisepticum before treatment was given. Subsequent 
samplings were performed on days 6, 7, 8, 9, 10 and 11 post 
hatching, and treatment was given on days 6, 7 and 8 post 
hatching.  Two  chicks  were  randomly  chosen  from  each 
group for each sampling that included pooled choanal cleft 
swabs from each group, as described previously. The storage 
and processing of samples collected were as described above. 
The antimicrobial used was a macrolide (labelled as Macrolide 1 
in this study). Treatment was given for three consecutive days 
in  the  drinking  water  at  the  dose  recommended  by  the 
manufacturer. Five out of nine in ovo inoculated chicks were 
given drug treatment, whilst the remaining four were left 
untreated.  The  treated  and  untreated  chicks  were  kept  in 
separate cages in the experimental house. Four chicks from 
the in ovo un-inoculated group served as the control group 
for this experiment.
In vivo study of drug efficacy under field 
conditions
Sacrificed chicks were obtained from a commercial broiler 
farm in Malaysia. The day-old chicks showed gasping and 
were sacrificed to find the reason behind this. The gasping 
chicks  were  shown  to  have  caseous  air  sac  lesions.  The 
sacrificed chicks, which were kept on ice, were sent to the 
laboratory on the same day. Post mortem examinations were 
carried out immediately after arrival of the chicks. Ten chicks 
were sacrificed on the farm on each sampling day. The first 
sampling was carried out on day-old chicks. Choanal cleft, 
tracheal and air sac swabs were obtained from each chick 
and the three swabs collected from each chick were pooled 
as one sample. Swab samples collected were immediately 
stored in PPLO broth that had been mixed with an equal 
volume of sterile glycerol and kept at -80 °C. The samples 
from the first day sampling were processed by extraction 
and amplification of DNA and RNA using PCR and RT-PCR, 
respectively, to verify the presence of M. gallisepticum before 
treatment was given.
During  the  period  of  verification,  culling  of  poor-quality 
chicks was carried out on the farm. Treatment was given on 
days 3, 4 and 5 post hatching. Subsequent sampling of 10 
sacrificed chicks was performed on day 8 post hatching. No 
sampling was performed during the treatment period. The 
same sampling methods were applied. A macrolide was used 
as the antimicrobial in this study (labelled Macrolide 2). Three 
days of treatment were given via the drinking water at the 
dose recommended by the manufacturer.
Interpretation of results
The amplicons derived from the primers used in the present 
study were designed to have a molecular size of 186 bp, that 
is, in proximity to the 200 bp marker following agarose gel 
electrophoresis. 
A positive PCR result indicated presence of M. gallisepticum 
DNA,  but  not  whether  M.  gallisepticum  was  viable  or 
not.  A  negative  PCR  result  suggested  possible  absence  of 
M. gallisepticum DNA in the sample, although this depended 
on  test  sensitivity.  A  positive  RT-PCR  result  indicated 
presence of viable M. gallisepticum, or recently inactivated 
M.  gallisepticum  (less  than  20  h  previously,  depending  on Original Research
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sampling,  transport  and  storage  conditions).  A  positive 
PCR,  negative  RT-PCR  result  indicated  the  presence  of 
M. gallisepticum DNA, but absence of RNA associated with 
the presence of inactivated organisms (inactivation having 
occurred more than 20 h previously, depending on sampling, 
transport  and  storage  conditions).  Negative  PCR  and  RT-
PCR indicated likely absence of M. gallisepticum DNA/RNA, 
and thus, the likely absence of the organism.
Ethical considerations
This work was conducted with the approval and financial 
support  of  the  Universiti  Putra  Malaysia  and  Ministry 
of  Science,  Technology  and  Innovation  (MOSTI),  project 
number 02-01-04-SF0370.
Results
In vitro verification of stability of 16S rRNA after 
mycoplasma death
The  stability  of  16S  rRNA  was  evaluated  by  RT-PCR  for 
the times shown in Table 1. The time when rRNA was last 
detected  ranged  from  20.3–25.0  h  when  stored  at  37  °C, 
22.7–25.7 h when stored at 16 °C; and 23.0–27.0 h when stored 
at 4 °C. Different methods of inactivation preserved rRNA 
for different durations. Of all the storage temperatures (4 °C, 
16 °C and 37 °C), ultrasonic inactivation allowed preservation 
of rRNA for the longest time, followed by osmotic and heat 
inactivation and, lastly, heat inactivation alone. A decrease in 
time of rRNA preservation was observed when the storage 
temperature  increased.  By  storing  under  4  °C  compared 
to  37  °C,  the  rRNA  preservation  time  was  increased  by 
2 h when ultrasonic inactivation was performed, 2 h when 
osmotic and heat inactivation were performed and 3 h when 
heat inactivation alone was used. All PCR results on rRNA 
were  negative,  indicating  absence  of  DNA  contamination 
following DNase treatment.
In vivo study of drug efficacy under 
experimental conditions
The PCR evaluation to verify the presence of M. gallisepticum 
DNA on day 0 indicated that M. gallisepticum infection was 
absent  in  the  control  group  but  present  in  both  treated 
and untreated groups (bands from wells 2 to 6), as shown 
in Figure 1. The same results were obtained from day 6 to 
day 8 (treatment given) and day 9 to day 11 post hatch (post 
treatment period), indicating the presence of the organism in 
the chicks up to day 11 post hatch.
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FIGURE 1: Agarose gel electrophoresis of PCR amplified experimental samples obtained 
on day 0. 
 
Well 1, marker; wells 2 and 3, treatment groups; wells 4 and 5, non-treatment groups; well 6, control group; well 7, PCR control.  
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Well 1, marker; wells 2 and 3, treatment groups; wells 4 and 5, non-treatment groups; well 
6, control group; well 7, PCR control. 
FIGURE 1: Agarose gel electrophoresis of polymerase chain reaction amplified 
experimental samples obtained on day 0.
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TABLE 1: The mean hour when rRNA was last evaluated by reverse transcription polymerase chain reaction when inactivated using three different methods and stored 
at 37 °C, 16 °C and 4 °C.
Strains Osmotic lysis and Heat lysis Ultrasonic lysis Heat lysis
37 °C 16 °C 4 °C 37 °C 16 °C 4 °C 37 °C 16 °C 4 °C
M. gallisepticum-S6 23 23 25 25 27 27 23 23 23
M. gallisepticum ts-11 25 27 27 23 25 27 15 22 23
M. gallisepticum H21-11T 23 23 25 27 27 27 13 23 22
Mean 23.7 25.0 25.7 25.0 25.7 27.0 20.3 22.7 23.0
M. gallisepticum, Mycoplasma gallisepticum; M. gallisepticum-S6, Reference strain; M. gallisepticum ts-11, Vaccine strain; M. gallisepticum H21-11T, Field strain.
The RT-PCR evaluation of viability of M. gallisepticum after 
Macrolide 1 treatment revealed that M. gallisepticum remains 
viable  from  the  first  day  of  treatment  up  to  day  2  post 
treatment (day 10 post hatch), as shown in Figure 2, where 
bands were present in both treated and untreated groups 
(wells 3 to 6). However, on day 3 post treatment (day 11 post 
hatch), one of the treated group showed a negative result (no 
band; well 8) for RT-PCR evaluation.
In vivo study of drug efficacy under field 
conditions
The PCR evaluation to verify the presence of M. gallisepticum 
infection at day 0 indicated that all 10 day 0 chicks that were 
sacrificed were M. gallisepticum infected, as shown in Figure 3, 
where bands were present from wells 3 to 12, indicating that 
the  infection  was  indeed  vertically  transmitted  from  hen 
to  eggs.  The  RT-PCR  evaluation  to  verify  the  viability  of 
M. gallisepticum at day 0 indicated that the M. gallisepticum 
detected in the chicks was all viable M. gallisepticum, as shown 
in Figure 4, where bands were present from wells 3−12. Original Research
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The PCR evaluation of the samples obtained at the second 
sampling on day 3 post treatment with Macrolide 2 (day 8 
post hatch) did not initially have any bands on agarose gel 
electrophoresis. It was suspected that the negative result was 
indeed  a  false  negative  result  due  to  low  M.  gallisepticum 
load; therefore, another PCR amplification was performed 
using a larger volume of DNA template and amplified for 
40 cycles instead of the initial 30 cycles. The result of the 
second  attempt  is  shown  in  Figure  5,  when  all  10  chicks 
sampled  were  M.  gallisepticum  infected  (bands  from  wells 
3  to  12).  The  RT-PCR  evaluation  of  samples  obtained  on 
day 3 post treatment with Macrolide 2 had a negative result, 
indicating  that  the  M.  gallisepticum  was  not  viable  in  the 
chicks sampled, except for one where M. gallisepticum was 
still viable (band at well 11), as shown in Figure 6.
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FIGURE 3: Agarose gel electrophoresis of PCR amplified field samples obtained on day 0. 
 
 
Well 1, PCR control; well 2, marker; wells 3 to 12, samples. 
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FIGURE 3: Agarose gel electrophoresis of polymerase chain reaction  amplified 
field samples obtained on day 0.
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FIGURE  2:  Agarose  gel  electrophoresis  of  RT-PCR  amplified  experimental  samples 
obtained on day 10 post hatch [wells 1−6] and day 11 post hatch [wells 7−12].  
 
 
Wells 1 and 7, control group; wells 3 and 4 (day 2 post Macrolide 1 treatment), 8 and 10 (day 3 post Macrolide 1 treatment), 
treated groups; wells 5 and 6, 11 and 12, untreated groups. 
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Wells 1 and 7, control group; wells 3 and 4 (day 2 post Macrolide 1 treatment), 8 and 10 (day 
3 post Macrolide 1 treatment), treated groups; wells 5 and 6, 11 and 12, untreated groups.
FIGURE  2:  Agarose  gel  electrophoresis  of  reverse  transcription  polymerase 
chain reaction  amplified experimental samples obtained on day 10 post hatch 
(wells 1−6) and day 11 post hatch (wells 7−12). 
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FIGURE 6: Agarose gel electrophoresis of RT-PCR amplified field samples obtained on day 
3 post treatment with Macrolide 2. 
 
 
Well 4, marker; well 1, PCR control; wells 2, 3, 5 to 12, chicks treated with Macrolide 2. 
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Well 4, marker; well 1, PCR control; wells 2, 3, 5 to 12, chicks treated with Macrolide 2.
FIGURE  6:  Agarose  gel  electrophoresis  of  reverse  transcription  polymerase 
chain reaction  amplified field samples obtained on day 3 post treatment with 
Macrolide 2.
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FIGURE 4: Agarose gel electrophoresis of RT-PCR amplified field samples obtained on day 
0.  
 
 
Well 1, PCR control; well 2, marker; wells 3 to 12, samples. 
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Well 1, marker; well 2, PCR control; wells 3 to 12, chicks treated with Macrolide 2.
FIGURE 5: Agarose gel electrophoresis of polymerase chain reaction  amplified 
field samples obtained on day 3 post treatment with Macrolide 2.
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FIGURE 4: Agarose gel electrophoresis of RT-PCR amplified field samples obtained on day 
0.  
 
 
Well 1, PCR control; well 2, marker; wells 3 to 12, samples. 
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Well 1, PCR control; well 2, marker; wells 3 to 12, samples.
FIGURE 4: Agarose gel electrophoresis of reverse transcription polymerase 
chain reaction amplified field samples obtained on day 0. Original Research
doi:10.4102/ojvr.v81i1.708 http://www.ojvr.org
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Discussion
During the RNA extraction for RT-PCR amplification, two 
successive  DNA  removals  were  performed  in  the  present 
study. This has a high tendency to cause further degradation 
of RNA due to the processing temperature, and the protein 
removal protocols may further dilute the concentration of 
the RNA template, so that a less than satisfactory amount 
of product is produced by RT-PCR amplification. A better 
way to remove DNA contamination is suggested whereby 
the volume of DNase enzymes is doubled and the incubation 
time in the water bath is increased instead of performing the 
protocol twice.
The  16S  rRNA  of  M.  gallisepticum  was  most  stable  when 
M. gallisepticum was inactivated using ultrasonic lysis, less 
stable using osmotic and heat lysis (60 °C, 1 h), and least stable 
using heat lysis alone (95 °C, 15 min). This finding coincides 
with the findings of Marois et al. (2002), where rRNA was 
last  detected  at  23  h  when  the  samples  were  inactivated 
by osmotic shock and heat treatment, and 20 h when the 
samples were inactivated by heat inactivation alone. Both 
were  stored  at  room  temperature  after  inactivation.  The 
differences in 16S rRNA stability observed amongst the three 
inactivation methods could be explained by the degree of 
RNase enzymes denaturation in each inactivation technique 
(Marois et al. 2002). A higher incidence of RNase denaturation 
leaves fewer enzymes to digest RNA; therefore, RNA persists 
longer in dead cells in such samples. From the results it can 
be said that the most effective inactivation of RNase occurred 
with ultrasonic lysis, which generates the highest intensity of 
heat, rather than during heat inactivation for 1 h at 60 °C, and 
least effective when inactivated at 95 °C for 15 min. Based 
on this, it is suggested that the persistence of rRNA in dead 
cells might depend on various conditions present at the time 
of mycoplasma death, which could influence the degree of 
RNA exposure to RNases and the rate of RNA degradation. 
The  results  obtained  in  the  present  study  confirm  the 
results obtained by Marois et al. (2002) on detection of 16S 
rRNA  stability  of  mycoplasma  cells.  The  results  obtained 
in this study also confirm the results obtained by Sheridan 
et al. (1998) and Kempsell and Kwok (1990) on detection of 
bacterial rRNA using an RT-PCR, which suggest the presence 
of live or recently dead bacteria.
In  field  conditions,  the  temperature  in  the  choanal  cleft 
of  chickens  is  approximately  30  °C.  RNases  are  unlikely 
to  be  inactivated  when  compared  to  post  treatment  with 
ultrasonic lysis at 60 °C or 95 °C. For this reason (and most 
probably  coupled  with  other  reasons  such  as  presence  of 
RNases  from  other  less  fragile  bacteria),  the  stability  of 
free rRNA of mycoplasma in field conditions is suggested 
to be less than 20.3 h (the shortest time for degradation of 
rRNA  in  the  present  study).  The  increase  in  the  duration 
of rRNA detection by 2–3 h when the storage temperature 
was decreased from 37 °C to 4 °C with all the inactivation 
methods  suggests  that  persistence  of  rRNA  in  dead  cells 
also  depends  on  the  storage  temperature.  It  is  therefore 
recommended that samples collected for the evaluation of 
M. gallisepticum viability should be stored on ice and sent to 
the laboratory within 20 h after sample collection. The time 
of sample collection should be clearly stated to ensure that 
samples are processed within the time limit of 20 h after 
sample collection.
The  artificial  induction  of  vertical  transmission  of 
M.  gallisepticum  using  intra-yolk  inoculation  resulted 
in  very  low  hatchability  in  commercial  broiler-breeder 
embryonated eggs. It was postulated that the extremely 
low  hatchability  was  due  to  the  concentration  of 
M. gallisepticum that was inoculated in ovo. It is therefore 
recommended  that  a  hatchability  test  should  be  carried 
out to determine a suitable M. gallisepticum concentration 
if artificial induction of vertical transmission were to be 
performed. On day 3 post treatment, one of the treated 
pairs  showed  a  negative  result  on  RT-PCR  evaluation, 
meaning that these chicks had non-viable M. gallisepticum 
that had been inactivated by Macrolide 1 at least 20 h before 
sampling. However, another group of chicks treated with 
Macrolide 1 still possessed viable M. gallisepticum, so the 
efficacy of Macrolide 1 could not be confirmed at day 3 
post treatment.
Upon RT-PCR evaluation in the field study, only one chick 
was shown to have viable M. gallisepticum. The remaining 
chicks  had  inactivated  or  dead  M.  gallisepticum.  This 
means  that  Macrolide  2  had  succeeded  in  inactivating 
M. gallisepticum in most of the chicks that were sampled. It 
is recommended that future studies on in vivo drug efficacy 
should have a longer duration and larger sample size in order 
to thoroughly evaluate the efficacy of antimicrobial drugs 
against M. gallisepticum infection. It is also recommended that 
a more sensitive technique, such as Real Time PCR, should 
be used to prevent incidence of false negatives, as occurred 
in the present study.
Conclusion
In conclusion, the present study shows that the stability of 
M. gallisepticum 16S rRNA can be evaluated up to 20–25 h 
at 37 °C, 22–25 h at 16 °C and 23–27 h at 4 °C. Therefore, 
RT-PCR  enables  the  detection  of  viable  or  recently  dead 
(less  than  20  h)  M.  gallisepticum.  RT-PCR  evaluation  of 
16S  rRNA  of  M.  gallisepticum  enables  detection  of  viable 
M.  gallisepticum.  PCR  enables  detection  of  both  viable 
and  non-viable  M.  gallisepticum,  without  differentiating 
between them. The combination of both PCR and RT-PCR 
enables  detection  and  differentiation  to  some  degree  of 
viable and non-viable M. gallisepticum. Thus, both methods 
should  be  used  for  detection  and  determination  of  viable 
M. gallisepticum in suspected cases. RT-PCR of 16S rRNA of 
M. gallisepticum is also found to be suitable and applicable 
under field conditions.Original Research
doi:10.4102/ojvr.v81i1.708 http://www.ojvr.org
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